Journal of Clinical Endocrinology & Metabolism, Vol 66, 199-207, Copyright © 1988 by Endocrine Society

ARTICLES

Intrathyroidal dendritic cells

PJ Kabel, HA Voorbij, M De Haan, RD van der Gaag and HA Drexhage
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.

The presence, marker pattern, and ultrastructure of antigen-presenting dendritic cells were studied in normal thyroid glands from 9 subjects (6 obtained at surgery; 3 at autopsy) and in the thyroid glands form 13 patients with Graves' hyperthyroidism, 10 patients with simple nontoxic goiter, and 1 patient with Hashimoto's disease (all obtained at surgery). The immunohistochemical characterization of the cells was carried out using the monoclonal antibodies OKIa (class II MHC determinants), RFD1 and L25. These latter monoclonal antibodies react strongly with active dendritic cells in T-cell areas of secondary lymphoid organs (the interdigitating cells in lymph nodes and spleen). Antigen-presenting dendritic cells were defined as cells with an eccentric reniform nucleus, long cytoplasmic protrusions, and strong membrane-bound class II MHC positivity combined with little or no cytoplasmic acid phosphatase activity. According to these criteria normal human thyroid tissue contained a few dendritic cells; they were localized outside the thyroid follicles. These dendritic cells in normal thyroid tissue lacked the marker molecules identified by the monoclonal antibodies RFD1 and L25. In fact, the majority of the dendritic cells were strongly positive for the C3bi receptor (identified by the monoclonal antibody FK 24), which indicates a more monocyte/macrophage character of the cell. In Hashimoto's goiter, Graves' disease, and sporadic nontoxic goiter (which we consider an autoimmune thyroid disease) the numbers of dendritic cells were higher compared to those in the normal gland, and these dendritic cells were clearly positive for RFD1 and L25. The cells were often seen in contact with a few intrathyroidal lymphocytes, forming small lymphoid cell clusters. They were also found in the T-cell zones of larger well organized intrathyroidal lymphoid structures (focal thyroiditis). On ultrastructural examination the dendritic cells in Graves' glands, Hashimoto's goiter, and sporadic nontoxic goiter were similar to the interdigitating cells present in secondary lymphoid organs. The data suggest active involvement of dendritic cells in the immune process in the thyroids of patients with autoimmune thyroid disease.

This article has been cited by other articles:

				D. El Fassi, C. H Nielsen, H. C Hasselbalch, and L. Hegedus The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur. J. Endocrinol., May 1, 2006; 154(5): 623 - 632. [Abstract] [Full Text] [PDF]

				A. Rios, J. M. Rodriguez, M. R. Moya, P. J. Galindo, M. Canteras, M. R. Alvarez, and P. Parrilla Associations of HLA-C Alleles With Multinodular Goiters: Study in a Population From Southeastern Spain. Arch Surg, February 1, 2006; 141(2): 123 - 128. [Abstract] [Full Text] [PDF]

				P. N. Pichurin, C.-R. Chen, G. D. Chazenbalk, H. Aliesky, N. Pham, B. Rapoport, and S. M. McLachlan Targeted Expression of the Human Thyrotropin Receptor A-Subunit to the Mouse Thyroid: Insight into Overcoming the Lack of Response to A-Subunit Adenovirus Immunization J. Immunol., January 1, 2006; 176(1): 668 - 676. [Abstract] [Full Text] [PDF]

				S. M. McLachlan, Y. Nagayama, and B. Rapoport Insight into Graves' Hyperthyroidism from Animal Models Endocr. Rev., October 1, 2005; 26(6): 800 - 832. [Abstract] [Full Text] [PDF]

				J. R. Klein and H.-C. Wang Characterization of a novel set of resident intrathyroidal bone marrow-derived hematopoietic cells: potential for immune-endocrine interactions in thyroid homeostasis J. Exp. Biol., January 1, 2004; 207(1): 55 - 65. [Abstract] [Full Text] [PDF]

				M. Bajenoff, S. Granjeaud, and S. Guerder The Strategy of T Cell Antigen-presenting Cell Encounter in Antigen-draining Lymph Nodes Revealed by Imaging of Initial T Cell Activation J. Exp. Med., September 2, 2003; 198(5): 715 - 724. [Abstract] [Full Text] [PDF]

				C. J.J Alderman, P. R Bunyard, B. M Chain, J. C Foreman, D. S Leake, and D. R Katz Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res, September 1, 2002; 55(4): 806 - 819. [Abstract] [Full Text] [PDF]

				F. G. A. Delemarre, P. J. Simons, H. J. de Heer, and H. A. Drexhage Signs of Immaturity of Splenic Dendritic Cells from the Autoimmune Prone Biobreeding Rat: Consequences for the In Vitro Expansion of Regulator and Effector T Cells J. Immunol., February 1, 1999; 162(3): 1795 - 1801. [Abstract] [Full Text] [PDF]

				M.A. Hoijer, M.J. Melief, J. Calafat, D. Roos, R.W.M. van den Beemd, J.J.M. van Dongen, and M.P. Hazenberg Expression and Intracellular Localization of the Human N-acetylmuramyl-L-alanine Amidase, a Bacterial Cell Wall-Degrading Enzyme Blood, August 1, 1997; 90(3): 1246 - 1254. [Abstract] [Full Text] [PDF]